Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations
出版年份 2015 全文链接
标题
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations
作者
关键词
-
出版物
CANCER
Volume 122, Issue 5, Pages 702-711
出版商
Wiley
发表日期
2015-12-11
DOI
10.1002/cncr.29826
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Optimizing Systemic Therapy for Bladder Cancer
- (2017) Sumanta K. Pal et al. Journal of the National Comprehensive Cancer Network
- Prognostic Factors in Urothelial Carcinoma of the Bladder
- (2015) James P. Solomon et al. ADVANCES IN ANATOMIC PATHOLOGY
- The Role of Genomics in the Management of Advanced Bladder Cancer
- (2015) Elizabeth A. Guancial et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Re: Whole-genome and Whole-exome Sequencing of Bladder Cancer Identifies Frequent Alterations in Genes Involved in Sister Chromatid Cohesion and Segregation
- (2015) Eugene K. Cha et al. EUROPEAN UROLOGY
- Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 Mutation
- (2015) Siraj M. Ali et al. EUROPEAN UROLOGY
- Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification
- (2015) Norma Palma et al. EUROPEAN UROLOGY
- Novel molecular targets for urothelial carcinoma
- (2015) Bishoy M Faltas et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review
- (2015) Vishal Vashistha et al. BMC CANCER
- Abstract CT326: Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors
- (2015) Lecia V. Sequist et al. CANCER RESEARCH
- Targeted therapies in urothelial carcinoma
- (2014) Monalisa Ghosh et al. CURRENT OPINION IN ONCOLOGY
- Response of an ERBB2-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2–Targeted Therapy
- (2014) Siraj M. Ali et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenic Alterations in ERBB2/HER2 Represent Potential Therapeutic Targets Across Tumors From Diverse Anatomic Sites of Origin
- (2014) J. Chmielecki et al. ONCOLOGIST
- Treatment of Metastatic Extramammary Paget's Disease Associated With Adnexal Adenocarcinoma, With Anti-HER2 Drugs Based on Genomic Alteration ERBB2 S310F
- (2014) O. Vornicova et al. ONCOLOGIST
- Molecular biomarkers for predicting outcomes in urothelial carcinoma of the bladder
- (2014) Nikhil Sapre et al. PATHOLOGY
- Erratum: Corrigendum: Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden
- (2014) J. -B. Cazier et al. Nature Communications
- Toward a Molecular Pathologic Classification of Urothelial Carcinoma
- (2013) Gottfrid Sjödahl et al. AMERICAN JOURNAL OF PATHOLOGY
- Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
- (2013) Firas Abdollah et al. Cancer Epidemiology
- Relapsed Classic E-Cadherin (CDH1)-Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations
- (2013) J. S. Ross et al. CLINICAL CANCER RESEARCH
- A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
- (2013) J. S. Ross et al. CLINICAL CANCER RESEARCH
- Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
- (2013) Julien Mazières et al. JOURNAL OF CLINICAL ONCOLOGY
- Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy
- (2013) Jeffrey S Ross et al. MODERN PATHOLOGY
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- Challenging current paradigms
- (2013) Aidan P. Noon et al. Nature Reviews Urology
- Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment
- (2013) Grit S. Herter-Sprie et al. Frontiers in Oncology
- Her2 amplification distinguishes a subset of non-muscle-invasive bladder cancers with a high risk of progression
- (2012) Paul Chih-Hsueh Chen et al. JOURNAL OF CLINICAL PATHOLOGY
- Diagnosis and Treatment of Bladder Cancer: How Can We Improve?
- (2012) Michael A. Gorin et al. POSTGRADUATE MEDICINE
- Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
- (2012) H. Greulich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
- (2012) Ron Bose et al. Cancer Discovery
- Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours
- (2011) Achim Fleischmann et al. EUROPEAN UROLOGY
- PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors
- (2011) F. Janku et al. MOLECULAR CANCER THERAPEUTICS
- How to apply de Bruijn graphs to genome assembly
- (2011) Phillip E C Compeau et al. NATURE BIOTECHNOLOGY
- Early Accelerated Approval for Highly Targeted Cancer Drugs
- (2011) Bruce A. Chabner NEW ENGLAND JOURNAL OF MEDICINE
- Role of anti-Her-2 therapy in bladder carcinoma
- (2010) Álvaro Pinto Marín et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Emerging Targeted Therapies for Breast Cancer
- (2010) Ricardo H. Alvarez et al. JOURNAL OF CLINICAL ONCOLOGY
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Bladder cancer
- (2009) Donald S Kaufman et al. LANCET
- Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications
- (2009) Mahul B Amin MODERN PATHOLOGY
- Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer
- (2009) Michael P. Porter et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The present and future burden of urinary bladder cancer in the world
- (2009) Martine Ploeg et al. WORLD JOURNAL OF UROLOGY
- Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
- (2008) Fabio Calabrò et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation